Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Executive Officer sold 6,126 shares at $13.01 ($79,717)
  2. 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $17.53 ($87,656)
  3. 4 Open-market sale Chief Technical Officer sold 11,000 shares at $17.64 ($194,052)
  4. 4 Open-market sale Mahmood Nadir sold 7,500 shares at $18.03 ($135,215)
  5. 4 Open-market sale Chief Technical Officer sold 11,593 shares at $15.51 ($179,783)
  6. 4 Open-market sale Mahmood Nadir sold 7,500 shares at $15.32 ($114,900)
  7. 4 Open-market sale Chief Technical Officer sold 3,000 shares at $13.41 ($40,230)
  8. 4 Open-market sale Mahmood Nadir sold 7,500 shares at $13.40 ($100,480)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Chief Executive Officer acquired 19,500 shares (grant or award)
  11. 4 Grant or award Mahmood Nadir acquired 6,000 shares (grant or award)
  12. 4 Grant or award Chief Legal Officer acquired 8,000 shares (grant or award)
  13. 4 Grant or award Chief Scientific Officer acquired 5,000 shares (grant or award)
  14. 4 Grant or award Sr. VP, Technical Operations acquired 2,500 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 11 · 218 filings